Chromosomal Abnormalities in Patients With Congenital Heart Disease at Assiut University Children's Hospital
- Conditions
- Congenital Heart Disease (CHD)Chromosomal Abnormalities
- Registration Number
- NCT07204509
- Lead Sponsor
- Assiut University
- Brief Summary
Congenital heart disease (CHD) is one of the most common birth defects and an important cause of infant morbidity and mortality. Many children with CHD also have underlying genetic abnormalities, particularly chromosomal abnormalities, which may affect their prognosis, management, and counseling. This study aims to determine the incidence and pattern of chromosomal abnormalities among children with CHD attending Assiut University Children's Hospital and Elmabara Insurance Hospital.
Children with a confirmed diagnosis of CHD will undergo a detailed clinical assessment, including dysmorphic evaluation, followed by chromosomal analysis (karyotyping). The study will help identify the frequency and type of chromosomal abnormalities associated with CHD and their correlation with specific cardiac defects and phenotypic features.
Understanding these genetic associations may improve diagnosis, early intervention, and family counseling, and provide useful information for risk stratification and prevention strategies in the Egyptian population.
- Detailed Description
Congenital heart disease (CHD) affects approximately 8-10 per 1,000 live births worldwide. Genetic factors, including chromosomal abnormalities such as trisomies and microdeletions, are strongly associated with the occurrence of CHD. Identifying such abnormalities is important for patient management, surgical planning, long-term prognosis, and genetic counseling.
This observational cross-sectional study will be conducted at Assiut University Children's Hospital (Pediatric Genetics Unit and Pediatric Cardiology Clinic) and Elmabara Insurance Hospital. A total of 138 children with confirmed structural CHD will be enrolled. Each patient will undergo:
Clinical evaluation including demographic data, detailed medical history, and physical examination.
Assessment of dysmorphic features and other congenital anomalies.
Cytogenetic evaluation using standard karyotyping to detect chromosomal abnormalities.
The primary outcome is to estimate the incidence of chromosomal abnormalities in children with CHD. Secondary outcomes include the correlation of specific chromosomal abnormalities with CHD subtypes and phenotypic features.
This study will contribute valuable data regarding the genetic background of CHD in Upper Egypt. The findings are expected to enhance the understanding of genotype-phenotype correlations, improve early diagnosis, and guide family counseling and preventive strategies.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 138
- Children with a confirmed diagnosis of congenital heart disease (by echocardiography and/or cardiology evaluation).
- Age between 1 month and 18 years.
- Patients attending Assiut University Children's Hospital or Elmabara Insurance Hospital during the study period.
- Informed consent obtained from parents or legal guardians.
- Patients with acquired (non-congenital) heart disease.
- Critically ill patients in unstable condition not suitable for blood sampling.
- Incomplete clinical data or refusal of parents/guardians to participate.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of Chromosomal Abnormalities among Children with Congenital Heart Disease At enrollment (karyotype performed at baseline during the study period: September 2025 - September 2026) Proportion of enrolled pediatric CHD patients with any chromosomal abnormality detected by conventional karyotyping of peripheral blood lymphocytes. Chromosomal abnormalities include numerical (e.g., trisomies, monosomies) and large structural rearrangements visible on karyotype.
Incidence of Chromosomal Abnormalities among Children with Congenital Heart disease At enrollment (karyotype performed at baseline during the study period: october 2025 - October 2026) Proportion of enrolled pediatric CHD patients with any chromosomal abnormality detected by conventional karyotyping of peripheral blood lymphocytes. Chromosomal abnormalities include numerical (e.g., trisomies, monosomies) and large structural rearrangements visible on karyotype.
- Secondary Outcome Measures
Name Time Method